PharVision Advisers’s AutoNation AN Stock Holding History

PharVision Advisers’s Portfolio AN Stock Details AN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,462	Closed	-$290K	–	665
2025 Q2	$290K	Buy	+1,462	New	+$264K	0.42%	88

Other funds holding AN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BWA

Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PharVision Advisers's AN Position: Q3 2025 in Review

PharVision Advisers sold out of AutoNation (AN) in Q3 2025, closing a stake of 1,462 shares — an estimated $290K sold.

PharVision Advisers first reported a position in AN in Q2 2025 and held it in 1 quarter. The position peaked at $290K in Q2 2025. 513 funds tracked by Wall St. Rank hold AN as of Q3 2025.

PharVision Advisers reported no remaining AutoNation position as of Q3 2025 after selling out during the quarter.
PharVision Advisers sold 1,462 AutoNation shares in Q3 2025, an estimated $290K.
PharVision Advisers first reported a position in AutoNation in Q2 2025 and held it in 1 quarter.
PharVision Advisers's AutoNation position peaked at $290K in Q2 2025.
513 funds tracked by Wall St. Rank held AutoNation as of Q3 2025.

Based on PharVision Advisers's 13F filing for Q3 2025, filed 17 Nov 2025.